Eyevensys: Eyevensys Enters Collaboration With Phillips-Medisize and Minnetronix Medical

PARIS and CAMBRIDGE, Mass.-Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, has entered into strategic engagements with U.S.-based medical device manufacturers Phillips-Medisize and Minnetronix Medical to develop the next generation of the company's core technology. Eyevensys has embarked on the development of a new generation of system devices focusing on optimizing their ease-of-use and manufacturability, the company said in a statement. Phillips-Medisize will be responsible for Ocular Device design optimization and the high-volume manufacturing capability to support the commercial launch, and Minnetronix Medical will fulfill the same responsibilities for the Pulse Generator component. Work at both contract manufacturers has been initiated, according to Eyevensys.